Clinical Trial for Patients Who Have Had a Recent Heart Attack

Study Description: This study is for patients who have had a heart attack within the past three days.

Principal Investigator: Emerson C. Perin, MD, PhD

The Stem Cell Center of the Texas Heart Institute at St. Luke’s Episcopal Hospital in Houston, Texas is actively recruiting patients for FDA-approved clinical studies investigating the use of stem cells in aiding with recovery in cases of a heart attack.

Acute myocardial infarction (heart attack) occurs when an artery that feeds the heart (coronary artery) becomes blocked and blood flow to that area of the heart is cut off leading to muscle damage. The usual course of therapy is to be admitted to a hospital, open the blocked artery with a balloon, stent, or surgical bypass, then placed on medicines hoping the heart will recover.

The Stem Cell Center is enrolling patients who have had a recent heart attack treated with balloon/stents in order to see if stem cell therapy would aid in the recovery of heart muscle. 

Inclusion Criteria

The Stem Cell Center is actively enrolling patients who meet the following criteria:

• Patients must be 18 years or older.
• Patients must be screened for eligibility immediately after heart attack.
• Have had a specific type of heart attack called STEMI.
• Patients need to have had a stent placed in one of the arteries of the heart within 3 days of chest pain onset that resulted in restoration of blood flow.

Many factors are considered before enrolling patients into a research study and enrollment varies according to inclusion criteria.

Enrollment Information

If you are a patient who wishes to be considered for this study please call us toll free at 1-866-924-STEM (7836), or complete our secure online Patient Information Form.

If you are a Physician and would like to refer a patient for consideration, please contact a study coordinator at 832-355-9405.